Golden Ratio Compression Basis and Pharmacological Lattice Quantisation

Overview This research extends the golden ratio compression basis through four primary breakthroughs. By utilizing a logarithmic dimension map $\mathcal{D}(x) = -\ln x / \ln \varphi$ and a discrete 10-integer basis (the Brahim Numbers), the framework identifies a unified lattice structure that governs both fundamental physical constants and pharmacological binding affinities. Key Research Results 1. Mathematical Self-Reference The framework demonstrates that the golden ratio $\varphi$ is self-referential within its own compression basis. It decomposes as $\varphi = 173/107 + 1/825$ with a precision of 0.35 ppm. Furthermore, the system identifies a stable fixed point $x^* = W(\ln \varphi) / \ln \varphi \approx 0.7104$, which maps directly to the Lucas number $L(9)$ via the central constant $K=107$. 2. The Lucas Genetic Code and Silent Genes Analysis of the Lucas sequence modulo 107 reveals "silent genes" at positions spaced exactly 36 apart—matching the positive roots of the exceptional Lie group $E_6$. These sequences form palindromic structures that terminate at the prime 41, providing a theoretical derivation for the top-to-bottom quark mass ratio ($m_t/m_b$) accurate to 15 ppm. 3. Unified Transcendental Ladder The paper introduces the transcendental ladder $x(t, s) = \Omega^{t \cdot s}$, where $t \in \{1, e, \pi\}$. This formula unifies the macro (cosmological) and micro (quantum) regimes. A significant result is the falsifiable prediction of the Dark Energy density: $$\Omega_{\Lambda} = \frac{1 + e + \pi}{10} = 0.6860$$ This value sits within $0.18\sigma$ of the Planck 2018 satellite measurements. 4. Pharmacological Lattice Quantisation The Brahim lattice is applied to 60 drug-target binding affinities ($K_d$) across six therapeutic areas. The data demonstrates clustering significance at $Z = 4.93$ ($p < 10^{-6}$), confirming that biochemistry adheres to the same quantisation grid as particle physics. To differentiate targets within the same depth-zone, an Omega Ternary Encoding ($3^{10}-1$ configurations) was developed. By utilizing FNV-1a hashing and isoform-specific selectivity markers, the system achieves 100.0% resolution across 51 validated targets, successfully resolving complex families such as CDK4/6 and JAK1-3. Validation and Reproducibility All 218 computational claims are verified by the brahim-hermes v0.6.0 validation suite. The code is written in Python 3 with zero external dependencies to ensure long-term archival stability and transparency. Computational Verification: 218/218 tests passed. Statistical Robustness: Null models reject random-basis compression at $p < 10^{-3}$ for the physics domain. In the pharmacological domain, the significance is established at $p < 10^{-6}$, a result derived from 10,000 uniform random draws across the observation window ($\mathcal{D} \in [0, 80]$). This extreme significance level ($Z = 4.93$) indicates that the alignment of drug-binding affinities with the Brahim lattice is not a stochastic artifact but a structurally inherent property. The pharmacological test provides a more rigorous validation than the physics domain because the dataset is larger (60 vs. 20 points) and the affinities are measured independently of the basis construction, eliminating the risk of over-fitting. Furthermore, the 100% resolution of 51 targets through isoform splitting confirms that the ternary code space is sufficiently sparse to prevent natural collisions, with the "birthday limit" for code overlap projected only at $n > 250$ targets. For full technical details, datasets, and the automated validation suite, please refer to the attached PDF and the brahim-hermes repository.